What are the potential side effects of escitalopram (an antidepressant medication) in patients, particularly those with pre-existing medical conditions such as impaired renal (kidney) or hepatic (liver) function?

Side Effects of Escitalopram

Escitalopram is generally well-tolerated with common side effects including nausea, insomnia, sexual dysfunction, and gastrointestinal symptoms, but serious risks include QTc prolongation, hyponatremia, abnormal bleeding, and serotonin syndrome—particularly in patients with hepatic or renal impairment who require dose adjustments. 1

Common Side Effects

The most frequently reported adverse effects include:

• Gastrointestinal symptoms: Nausea, diarrhea (9%), dry mouth, constipation, and decreased appetite 1, 2
• Sleep disturbances: Insomnia (36%) and trouble sleeping 1, 2
• Neurological effects: Dizziness, headache, weakness, and feeling anxious 1
• Sexual dysfunction: Decreased libido, ejaculatory delay or failure in males, and delayed or absent orgasm in females 1
• Other common effects: Sweating, shaking, yawning (16%), and infection 1, 2

In children and adolescents, additional side effects include increased thirst, abnormal increase in muscle movement or agitation, nosebleed, difficult urination, heavy menstrual periods, and possible slowed growth rate requiring height and weight monitoring 1.

Serious Adverse Effects Requiring Monitoring

Cardiovascular Risks

Escitalopram carries a higher risk of QTc prolongation compared to other SSRIs like sertraline, making it less preferable in patients with cardiovascular disease 3. This is particularly important as citalopram and escitalopram have been specifically identified as having greater QTc prolongation risk than other SSRIs 3.

Hyponatremia

• Elderly patients and those taking diuretics or who are volume depleted are at greatest risk for developing hyponatremia 1
• Signs include headache, difficulty concentrating, memory impairment, confusion, weakness, and unsteadiness leading to falls 1
• Severe cases can present with hallucination, syncope, seizure, coma, respiratory arrest, and death 1
• Discontinuation should be considered in symptomatic patients with appropriate medical intervention 1

Bleeding Risk

• Escitalopram increases bleeding risk, particularly when combined with NSAIDs, aspirin, warfarin, or other anticoagulants 1
• Bleeding events range from ecchymoses, hematomas, epistaxis, and petechiae to life-threatening gastrointestinal hemorrhages 1

Hepatotoxicity

Although rare, cholestatic liver injury can occur with escitalopram, presenting as fever, abdominal pain, hepatomegaly, and elevated transaminases 4. Liver function should be monitored, especially in patients with pre-existing liver disease, as most patients may remain asymptomatic 4.

Serotonin Syndrome

Serotonin syndrome is a potentially life-threatening condition that can occur with escitalopram, particularly at higher doses (≥30 mg/day) or when combined with other serotonergic agents 5. Risk is increased when combined with triptans, tramadol, tricyclics, lithium, other SSRIs/SNRIs, amphetamines, antipsychotics, tryptophan, or St. John's Wort 1.

Special Population Considerations

Hepatic Impairment

In patients with hepatic impairment, escitalopram clearance is decreased and plasma concentrations are increased, requiring dose reduction to 10 mg/day maximum 1.

Renal Impairment

Escitalopram should be used with caution in severe renal impairment, though excretion of unchanged drug in urine is a minor route of elimination 1. Dose adjustment may be necessary 1.

Pregnancy and Breastfeeding

• Taking escitalopram late in pregnancy may increase risk of certain problems in newborns 1
• Escitalopram passes into breast milk, requiring discussion about feeding options 1

Temporal Profile and Dose Responsiveness

Side effects occurring within the first 2 weeks of treatment are associated with increased likelihood of trial completion (86.7% vs 73.7%), suggesting early side effects may not predict long-term tolerability 6. Side effects that resolve before a dose increase are unlikely to recur after the increase, but only 45% of intolerable side effects requiring dose reduction resolve within 30 days 6.

Discontinuation Syndrome

Abrupt discontinuation can cause withdrawal symptoms including dizziness, sensory disturbances, agitation, anxiety, nausea, and sweating, necessitating gradual tapering 7, 1.

Cognitive and Motor Impairment

While escitalopram 10 mg/day did not produce impairment in controlled studies, patients should be cautioned about operating hazardous machinery until they are certain the medication does not affect their ability 1.